NICOTRA, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 5.186
AS - Asia 3.433
EU - Europa 2.886
SA - Sud America 394
AF - Africa 71
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 5
Totale 11.985
Nazione #
US - Stati Uniti d'America 5.024
SG - Singapore 1.198
CN - Cina 914
DE - Germania 626
VN - Vietnam 529
IT - Italia 447
SE - Svezia 426
HK - Hong Kong 338
RU - Federazione Russa 327
BR - Brasile 294
IE - Irlanda 281
UA - Ucraina 280
GB - Regno Unito 161
CA - Canada 121
FR - Francia 102
FI - Finlandia 87
IN - India 84
BD - Bangladesh 53
KR - Corea 45
TR - Turchia 45
IQ - Iraq 36
AR - Argentina 31
NL - Olanda 31
ID - Indonesia 26
MX - Messico 23
UZ - Uzbekistan 23
ZA - Sudafrica 23
BE - Belgio 22
CO - Colombia 21
ES - Italia 21
PK - Pakistan 21
EC - Ecuador 18
PH - Filippine 18
SA - Arabia Saudita 18
PL - Polonia 17
JP - Giappone 12
MA - Marocco 10
IR - Iran 9
JO - Giordania 9
NP - Nepal 9
TN - Tunisia 9
VE - Venezuela 9
AZ - Azerbaigian 8
CL - Cile 8
RS - Serbia 8
BY - Bielorussia 7
DZ - Algeria 7
EU - Europa 7
KE - Kenya 7
AT - Austria 6
CZ - Repubblica Ceca 6
MY - Malesia 6
AU - Australia 5
EG - Egitto 5
JM - Giamaica 5
LB - Libano 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
LT - Lituania 4
LV - Lettonia 4
PE - Perù 4
PY - Paraguay 4
BO - Bolivia 3
CH - Svizzera 3
ET - Etiopia 3
HN - Honduras 3
IL - Israele 3
MD - Moldavia 3
NG - Nigeria 3
OM - Oman 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
BH - Bahrain 2
CR - Costa Rica 2
DK - Danimarca 2
HR - Croazia 2
KZ - Kazakistan 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
AL - Albania 1
AO - Angola 1
AP - ???statistics.table.value.countryCode.AP??? 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BT - Bhutan 1
CV - Capo Verde 1
GT - Guatemala 1
GY - Guiana 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MK - Macedonia 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
Totale 11.980
Città #
Singapore 669
Ann Arbor 527
Ashburn 418
San Jose 412
Frankfurt am Main 409
Woodbridge 408
Chandler 359
Hong Kong 333
Jacksonville 297
Fairfield 271
Dublin 268
Hangzhou 204
Houston 187
Dearborn 171
New York 152
Santa Clara 147
Beijing 137
Ho Chi Minh City 118
Milan 115
Seattle 106
Wilmington 105
Princeton 104
Cambridge 85
Hanoi 85
The Dalles 82
Chicago 75
Shanghai 71
Dong Ket 69
Los Angeles 64
Nanjing 60
Lachine 51
Lauterbourg 48
Seoul 44
Moscow 40
Buffalo 38
Altamura 36
Dallas 35
Toronto 35
Helsinki 33
Rome 33
Lawrence 32
São Paulo 28
Hebei 26
Orem 26
Changsha 24
Da Nang 24
Hefei 24
Shenyang 24
Boardman 22
Tianjin 22
Andover 20
Baghdad 18
London 18
Council Bluffs 17
Guangzhou 17
Munich 17
Brussels 16
Tashkent 16
Washington 15
Amsterdam 14
Falls Church 14
Nanchang 14
Zhengzhou 14
Chennai 13
Haiphong 13
Montreal 12
Ottawa 12
Warsaw 12
Boston 11
Düsseldorf 11
Jinan 11
Quito 11
San Diego 11
Biên Hòa 10
Jeddah 10
Jiaxing 10
Mumbai 10
Atlanta 9
Dhaka 9
Medellín 9
Ningbo 9
Norwalk 9
Stockholm 9
Wuhan 9
Amman 8
Johannesburg 8
Lahore 8
Nürnberg 8
San Francisco 8
Venezia 8
Baku 7
Brooklyn 7
Denver 7
Fremont 7
Hải Dương 7
Thái Nguyên 7
Tokyo 7
Columbus 6
Curitiba 6
Istanbul 6
Totale 7.698
Nome #
Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study 580
External adjustment for unmeasured confounders improved drug-outcome association estimates based on health care utilization data 388
Better compliance to antihypertensive medications reduces cardiovascular risk 330
Statins and the risk of diabetes: Evidence from a large population-based cohort study 328
Insulin and other antidiabetic drugs and hepatocellular carcinoma risk: A nested case-control study based on Italian healthcare utilization databases 303
A validation study of a new classification algorithm to identify rheumatoid arthritis using administrative health databases: Case-control and cohort diagnostic accuracy studies. Results from the RECord linkage on Rheumatic Diseases study of the Italian Society for Rheumatology 302
Cardiovascular protection by initial and subsequent combination of antihypertensive drugs in daily life practice 301
Management of antihypertensive drugs in three European countries 285
Cost-effectiveness of enhancing adherence to therapy with statins in the setting of primary cardiovascular prevention. Evidence from an empirical approach based on administrative databases. 282
Persistence with oral and transdermal hormone replacement therapy and hospitalisation for cardiovascular outcomes 274
Utilizzo di antidepressivi e rischio di frattura. 272
Metformin, other antidiabetic drugs, and endometrial cancer risk: a nested case–control study within Italian healthcare utilization databases 270
Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation 265
Issues concerning the use of hormone replacement therapy and risk of fracture: a population-based, nested case-control study. 263
Cardiovascular Protection by Initial and Subsequent Combination of Antihypertensive Drugs in Daily Life Practice. 260
Modelli flessibili per stimare gli effetti cumulati nei farmaci. 256
Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies 255
Una miglior compliance ai farmaci antipertensivi riduce il rischio cardiovascolare 250
Identificazione dei casi di BPCO nei database sanitari amministrativi: il progetto CRACK-CRD. 246
Long-term use of statins reduces the risk of hospitalization for dementia 244
Better compliance to antihypertensive medications reduces cardiovascular risk 242
La persistenza medica e l'uso di farmaci antipertensivi generici e brand. 232
Il propensity score nei disegni ambidirezionali in farmacoepidemiologia. 230
Potential Bias when excluding concepts from terminologies with different granularity: an illustration in the SOS Project 227
Meta-analisi della letteratura sulla relazione tra esposizione a insulina glargine e rischio di tumore. 226
Associazione tra alcuni fattori socioeconomici e incidenza delle terapie farmacologiche antipertensive e il loro mantenimento. 219
Una migliore compliance ai farmaci antipertensivi riduce il rischio cardiovascolare. 219
Confronto tra metodi per la correzione della distorsione dovuta al trend temporale nell'esposizione negli studi case-only. 216
Screening for gestational diabetes (GDM) in the Lombardy region: a population-based study 209
Cost-effectiveness analysis of enhancing adherence to bisphosphonates therapy in the setting of primary prevention of osteoporotic fractures. 208
Individual NSAIDs and upper gastrointestinal complications: A systematic review and meta-analysis of observational studies (the SOS Project) 200
Derivation and Validation of a Diagnostic Algorithm to Identify Patients with Rheumatoid Arthritis in Administrative Health Database 199
Use of antidepressant serotoninergic medications and cardiac valvulopathy: a nested case-control study in the health improvement network (THIN) database 198
A comparison of incidence rates of upper gastrointestinal complications estimated from different data sources in the safety of NSAIDs. 198
Analisi costo - efficacia dell'utilizzo di bifosfonati nella prevenzione primaria delle fratture osteoporotiche. 195
Revisione sistematica della letteratura sulla relazione tra esposizione a farmaci antidiabetici e rischio di tumore. 192
Comparison of different methods for the calculation of duration of NSAIDs use using different databases in the SOS Project 190
A UMLS-based approach for the homogeneous identification of events in seven European health databases: A contribution to the safety of NSAIDs (SOS) Project 188
Effetto dell'andamento temporale dell'esposizione sulle stime basate sul disegno case-crossover: proposta di un modello di correzione 187
Immeasurable time bias nello studio dell'associazione tra utilizzo di bifosfonati orali e rischio di sanguinamento gastrointestinale. 187
Risk of upper gastrointestinal complications associated with use of individual non-steroidal anti-inflammatory drugs in the SOS Project. 180
Incidence Rates of Hospitalization for Heart Failure in Europe. A Comparison Between Different Data Sources in the SOS Project. 179
A probabilistic bias analysis for misclassified categorical exposures, with application to oral anti-hyperglycaemic drugs 179
Screening for gestational diabetes in the Lombardy region: A population-based study 178
Use of non-steroidal anti-inflammatory drugs (NSAIDs) in Europe: The SOS Project. 178
Risk Models for predicting stroke and Upper Gastrointestinal Complications in NSAID Users: the SOS Project 177
Stima del rischio di tumore nei soggetti affetti da diabete di tipo 2 in funzione del trattamento farmacologico 176
Come integrare le informazioni disponibili dagli archivi elettronici clinici e da quelli amministrativi e applicazione alla stima del rischio di tumore nei soggetti affetti da diabete in funzione del trattamento farmacologico. 174
The effect of Daily Dose of Individual NSAIDs on the Risk of HF in the Safety of Non-Steroidal Anti - Inflammatory Drugs (SOS) Project 166
NSAID use among children in Europe in the SOS Project 163
Use of non-steroidal anti-inflammatory drugs and heart failure risk in the safety of non-steroidal anti-inflammatory drugs (SOS) Project. 163
The SOS project: incidences of reported cardiovascular events in RCTs 149
Totale 12.178
Categoria #
all - tutte 37.011
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.011


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021188 0 0 0 0 0 0 0 0 0 0 22 166
2021/2022581 11 51 34 72 42 61 34 32 30 48 43 123
2022/20231.467 147 431 208 119 104 185 11 83 89 14 48 28
2023/2024843 19 24 48 46 101 262 166 19 56 10 5 87
2024/20251.517 108 205 116 61 145 60 61 45 138 209 178 191
2025/20263.782 330 175 306 316 589 233 795 182 368 431 57 0
Totale 12.178